Pharmaceutical & Medical Product Information

Rachel Harris Appointed to Plantiff’s Steering Committee in Eliquis Products Liability Litigation

Schlichter Bogard & Denton is pleased to announce that Rachel Harris has been appointed to the Plaintiffs’ Steering Committee (PSC) in the Eliquis (Apixaban) Products Liability Litigation pending in the U.S. District Court for the Southern District of… Read More

Ashley Brittain Landers Appointed to Plaintiff’s Steering Committee in Invokana Products Liability Litigation

Schlichter Bogard & Denton is pleased to announce that Ashley Brittain Landers has been appointed to the Plaintiffs’ Steering Committee (PSC) in the Invokana (Canagliflozin) Products Liability Litigation pending in the U.S. District Court for the District… Read More

Invokana Patients Seek to Consolidate in Multidistrict Litigation

On Sept. 22, 2016 patients who suffered kidney failure, ketoacidosis, or a heart condition after taking the popular type 2 diabetes medications Invokana and Invokamet requested that the Judicial Panel on Multidistrict Litigation consolidate at least 56… Read More

Roger Denton and Kristine Kraft Appointed to Leadership Counsel for Just for Men Mass Tort Litigation

On July 7, 2016, Honorable Judge David Herndon of the United States District Court for the Southern District of Illinois, who is presiding over the Just for Men® Mass Tort Litigation, (Case no. 3:16-cv-00638-DRH Master Docket), appointed Schlichter Bogard… Read More

Kristine Kraft Appointed to Plaintiffs' Steering Committee in National Bair Hugger Multidistrict Litigation

On February 23, 2016, the Honorable Joan N. Ericksen, sitting in the U.S. District Court for the District of Minnesota, appointed Kristine Kraft of Schlichter, Bogard & Denton, LLP to the Plaintiffs' Steering Committee (PSC) in the national Bair Hugger… Read More

A Rising Anti-Stroke Drug Is Tied to Risk of Bleeding Deaths

New York Times By Katie Thomas 11/02/2012 Dr. Bryan A. Cotton, a trauma surgeon in Houston, had not heard much about the new anti-clotting drug Pradaxa other than the commercials he had seen during Sunday football games. Then people using Pradaxa… Read More

Study Confirms the Dangers of Yaz®, Yasmin®, and Ocella®

Schlichter Bogard & Denton 10/27/2011 All birth control pills carry some risk of causing blood clots. However, recent studies have shown that Yaz, Yasmin, and Ocella may carry a higher risk of causing blood clots than other birth control pills. Birth… Read More

ABC News Investigation: Studies Find Yaz® More Risky Than Other Leading Birth Control Pills

ABC News by Chris Cuomo 10/14/2011 ABC News covers the story of Carissa Ubersox, a young pediatric nurse who blames Yaz for causing her to go blind and nearly killing her at the age of 24. As reported by ABC, while all birth control pills carry some… Read More

FDA Warns of Increased Risk of Blood Clots associated with Yaz®, Yasmin®, and Ocella®

FDA 05/31/2011 The FDA is further reviewing the risk and expects to have results of its investigation later this summer. On May 31, 2011, the Food and Drug Administration (FDA) issued a Safety Alert directed to women who use Yaz, Yasmin, Ocella, and… Read More

Yaz®, Yasmin®, and Ocella® are Two to Three Times More Likely to cause Dangerous Blood Clots than other Common Birth Control Pills

British Medical Journal 04/21/2011 Yaz, Yasmin, and Ocella also pose an increased risk of gallbladder disease as compared to other common birth control pills.   While all birth control pills carry some risk of causing a blood clot, the risk caused… Read More